Lead author David Eckwright shares more about the study “Real-World Extended Dosing Assessment for Eye(s) new to Faricimab-svoa Therapy.”

publications Summer 2024 Prime Therapeutics Report June 11, 2024 The Prime Therapeutics Report is your source for innovative managed care strategies, trends and updates. This issue’s cover story...

The Prime Therapeutics Report is your trusted source for the latest in managed care strategies, specialty drug trends and payer-focused insights. The Summer 2025 issue features a cover story on HIV...

Hemophilia Federation of America HemophiliaFed.org Hemophilia Schedule now Your browser does not support inline frames or is currently configured not to display inline frames. Content can be viewed...

Notice of privacy practices Effective Date: March 2023 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE...

See the difference Explore solutions Get expert insights We don't chase the highest margins. We don’t steer to our pharmacies. And we don’t hide behind complexity. That's why our customers trust us...

Home Careers Hub + Home Relationships thrive at our hub Through our Hub and Home approach, we offer true flexibility, with many employees working primarily from home and others working in an...

A roundup of Prime's award-winning presentations and insights at AMCP Nexus in Las Vegas.